Balloon

(redirected from Intragastric Balloon)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

Balloon Loan

A loan or bond in which the borrower makes only interest payments for a set period of time. At the end of the term, the borrower repays the entire principal at once. A balloon loan may be useful when the borrower expects interest rates to be low at the end of the term, allowing him/her simply to refinance the loan. However, there is a high risk of default because not all borrowers actually have the cash to repay an entire loan in one payment. See also: Balloon Mortgage.
Farlex Financial Dictionary. © 2012 Farlex, Inc. All Rights Reserved

Balloon

The loan balance remaining at the time the loan contract calls for full repayment.

The Mortgage Encyclopedia. Copyright © 2004 by Jack Guttentag. Used with permission of The McGraw-Hill Companies, Inc.
Mentioned in ?
References in periodicals archive ?
The intragastric balloon - smoothing the path to bariatric surgery.
Intragastric balloon treatment of obesity: Long-term results and patient satisfaction
Intragastric balloon in the treatment of super-morbid obesity.
Development of Bariatric and Metabolic Endoscopy
According to the company, this was the first procedure of its kind in Texas since the FDA approved the Orbera Intragastric Balloon System and the ReShape Integrated Dual Balloon System for use with weight loss patients in the US.
Orbera Intragastric Balloon Makes Texas Debut
Brazilian multicentric study of the intragastric balloon. Obesity Surgery.
Intragastric balloon: evolution of a multidisciplinary clinical treatment in weight loss and waist circumference/Balao intragastrico: evolucao do tratamento clinico multidisciplinar na perda de peso e circunferencia abdominal
Despite achieving great results over the years, certain weaknesses and limitations in the traditional intragastric balloon have been detected.
Adjustable version of gastric balloon is now available; A Welsh clinic is pioneering the use of a gastric balloon to help people lose weight. Manny Srivastava, founder of Nucleus Healthcare, explains the latest developments in the technology which can result in weight loss of up to five stone over a year
From 2005 to 2015, 135 obese patients with NAFLD received treatment with the BioEnterics Intragastric Balloon (BIB; Allergan, Goleta, CA, USA) at a single tertiary hospital (Guy's and St Thomas' Hospital, London, UK).
Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre
The intragastric balloon can be placed in an outpatient setting.
Endoscopic Bariatric Options Show Promise as Obesity Treatments, According to the American Society for Gastrointestinal Endoscopy
Apollo Endosurgery announced completion of enrollment in the ORBERA Post Approval Study evaluating the ORBERA intragastric balloon. The ORBERA Post Approval Study is a multi-center, open-label, prospective study of the safety and efficacy of the ORBERA system within the US.
Apollo Endosurgery completes enrollment for ORBERA study
M2 PHARMA-August 6, 2015-US FDA Clears Apollo Endosurgery Orbera Intragastric Balloon for Weight Loss
US FDA Clears Apollo Endosurgery Orbera Intragastric Balloon for Weight Loss
The saline-filled Bioenterics intragastric balloon (BIB) and the air-Idled Heliosphere intragastric balloon are in use in some European and South American countries, Mexico, and Canada, he said.
Gastric bypass surgery alternatives nearing market
Apollo Endosurgery announced the presentation of results from Mayo Clinic's prospective open-label study of the Orbera Intragastric Balloon in patients with Nonalcoholic Steatohepatitis, or NASH, at Digestive Disease Week 2018.
Apollo Endosurgery announces results from Orbera study at Digestive Disease Week

Financial browser ?
Full browser ?